Skip to content

Generation of Haploid Stem Cells From Human Germ Cells

Generation of Haploid Stem Cells From Human Germ Cells

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01454765
Enrollment
10
Registered
2011-10-19
Start date
2011-12-31
Completion date
2015-08-31
Last updated
2013-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induced Pluripotent Stem Cells

Brief summary

Human cells are diploid (contain a double set of chromosomes). The diploid genome is complex and therefore limits genetic research approaches in biomedical models. To overcome this problem experimental generation of haploid stem cells has been done in animals. The investigators aim at generating haploid stem cells from human germ cells that are a useful tool in genetic research and screening.

Detailed description

Human cells are diploid (contain a double set of chromosomes). The diploid genome is complex and therefore limits genetic research approaches in biomedical models. To overcome this problem experimental generation of haploid stem cells has been done in animal models. haploid cells are easier for genetic manipulations, such as knock-in and knock-out of genes, and therefore should make a better experimental model. The investigators aim at generating haploid stem cells from human haploid germ cells.

Interventions

OTHERgeneration of stem cells

Collected germ cells will be cultured in medium. The germ cell cultures will be infected with reprograming factors. Rare colonies with characteristic stem cell morphologies will be expanded.

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. males over the age of 18 and under 50 2. no known chronic illness 3. not taking any chronic drugs

Exclusion criteria

1. females 2. males under 18 or over 50 3. any known chronic illness 4. taking chronic medications

Design outcomes

Primary

MeasureTime frameDescription
Patients donated samplesJune 2011-November 2013No samples collected to date

Secondary

MeasureTime frame
No secomdary outcomeJune 2011 - November 2013

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026